Exacerbation of Crohn's disease as paradoxical effect of infliximab

J Crohns Colitis. 2012 Apr;6(3):396. doi: 10.1016/j.crohns.2012.01.001. Epub 2012 Jan 20.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Anti-Inflammatory Agents / adverse effects*
  • Anti-Inflammatory Agents / therapeutic use
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Crohn Disease / drug therapy*
  • Disease Progression*
  • Female
  • Humans
  • Infliximab

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Infliximab